CO2019010062A2 - Novedoso bacteriófago clo-pep-2 de clostridium perfringens y su uso para inhibir la proliferación de clostridium perfringens - Google Patents

Novedoso bacteriófago clo-pep-2 de clostridium perfringens y su uso para inhibir la proliferación de clostridium perfringens

Info

Publication number
CO2019010062A2
CO2019010062A2 CONC2019/0010062A CO2019010062A CO2019010062A2 CO 2019010062 A2 CO2019010062 A2 CO 2019010062A2 CO 2019010062 A CO2019010062 A CO 2019010062A CO 2019010062 A2 CO2019010062 A2 CO 2019010062A2
Authority
CO
Colombia
Prior art keywords
clostridium perfringens
pep
proliferation
inhibit
clo
Prior art date
Application number
CONC2019/0010062A
Other languages
English (en)
Inventor
Seong Jun Yoon
Hee Jeong Shin
Jee Soo Son
Sang Hyeon Kang
Soo Youn Jun
Hyoun Rok Paik
Original Assignee
Intron Biotechnology Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intron Biotechnology Inc filed Critical Intron Biotechnology Inc
Publication of CO2019010062A2 publication Critical patent/CO2019010062A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/195—Antibiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/60—Feeding-stuffs specially adapted for particular animals for weanlings
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/70—Feeding-stuffs specially adapted for particular animals for birds
    • A23K50/75—Feeding-stuffs specially adapted for particular animals for birds for poultry
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L3/00—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs
    • A23L3/34—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals
    • A23L3/3454—Preservation of foods or foodstuffs, in general, e.g. pasteurising, sterilising, specially adapted for foods or foodstuffs by treatment with chemicals in the form of liquids or solids
    • A23L3/3463—Organic compounds; Microorganisms; Enzymes
    • A23L3/3571—Microorganisms; Enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae
    • C12N2795/10321—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae
    • C12N2795/10332—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Polymers & Plastics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Animal Husbandry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Physiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Fodder In General (AREA)

Abstract

La presente invención se refiere a un bacteriófago Siphoviridae Clo-PEP-2 (número de acceso: KCTC 13185BP) aislado de la naturaleza, que tiene la capacidad de matar Clostridium perfringens y tiene el genoma representado por la SEQ ID NO: 1, y a un método para prevenir o tratar una enfermedad causada por Clostridium perfringens usando una composición que contiene el bacteriófago Siphoviridae Clo-PEP-2 como ingrediente activo.
CONC2019/0010062A 2017-02-24 2019-09-17 Novedoso bacteriófago clo-pep-2 de clostridium perfringens y su uso para inhibir la proliferación de clostridium perfringens CO2019010062A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020170024557A KR101823860B1 (ko) 2017-02-24 2017-02-24 신규한 클로스트리디움 퍼프린젠스 박테리오파지 Clo-PEP-2 및 이의 클로스트리디움 퍼프린젠스 균 증식 억제 용도
PCT/KR2018/000513 WO2018155814A1 (ko) 2017-02-24 2018-01-11 신규한 클로스트리디움 퍼프린젠스 박테리오파지 Clo-PEP-2 및 이의 클로스트리디움 퍼프린젠스 균 증식 억제 용도

Publications (1)

Publication Number Publication Date
CO2019010062A2 true CO2019010062A2 (es) 2019-09-30

Family

ID=61083382

Family Applications (1)

Application Number Title Priority Date Filing Date
CONC2019/0010062A CO2019010062A2 (es) 2017-02-24 2019-09-17 Novedoso bacteriófago clo-pep-2 de clostridium perfringens y su uso para inhibir la proliferación de clostridium perfringens

Country Status (7)

Country Link
US (1) US11529406B2 (es)
KR (1) KR101823860B1 (es)
CN (1) CN110719953B (es)
CO (1) CO2019010062A2 (es)
MX (1) MX2019009964A (es)
RU (1) RU2748805C2 (es)
WO (1) WO2018155814A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101823860B1 (ko) 2017-02-24 2018-01-31 주식회사 인트론바이오테크놀로지 신규한 클로스트리디움 퍼프린젠스 박테리오파지 Clo-PEP-2 및 이의 클로스트리디움 퍼프린젠스 균 증식 억제 용도
CN111662880B (zh) * 2020-05-25 2022-06-17 江苏省农业科学院 一株产气荚膜梭菌噬菌体、包括噬菌体的抑菌剂及制备方法和应用
CN111690620B (zh) * 2020-07-17 2022-05-06 青岛诺安百特生物技术有限公司 一株魏氏梭菌噬菌体、其噬菌体组合物及其应用
CN114621932B (zh) * 2021-05-20 2023-11-24 青岛诺安百特生物技术有限公司 一株新型魏氏梭菌噬菌体、包含该噬菌体的噬菌体组合物及其在兔魏氏梭菌病中的应用
CN114958779B (zh) * 2022-01-21 2023-09-22 华中农业大学 一株能够裂解产气荚膜梭菌的噬菌体lpcpa6及应用
CN117586966B (zh) * 2023-11-21 2024-04-26 青岛润达生物科技有限公司 一株耐酸碱产气荚膜梭菌噬菌体rdp-cp-22005及其应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120076710A (ko) * 2010-12-30 2012-07-10 주식회사 인트론바이오테크놀로지 클로스트리디움 퍼프린젠스 특이 박테리오파지 ｃｐｐ-3
KR101381797B1 (ko) * 2013-02-27 2014-04-07 씨제이제일제당 (주) 신규 박테리오파지 및 이를 포함하는 항균 조성물
KR101381798B1 (ko) 2013-02-27 2014-04-07 씨제이제일제당 (주) 신규 박테리오파지 및 이를 포함하는 항균 조성물
KR101649849B1 (ko) 2014-12-29 2016-08-22 주식회사 인트론바이오테크놀로지 신규한 클로스트리디움 퍼프린젠스 박테리오파지 Ｃｌｏ-ＰＥＰ-1 및 이의 클로스트리디움 퍼프린젠스 증식 억제 용도
KR20160013243A (ko) * 2016-01-27 2016-02-03 주식회사 인트론바이오테크놀로지 클로스트리디움 퍼프린젠스 감염을 방지 및 처치하는 방법
KR101823860B1 (ko) 2017-02-24 2018-01-31 주식회사 인트론바이오테크놀로지 신규한 클로스트리디움 퍼프린젠스 박테리오파지 Clo-PEP-2 및 이의 클로스트리디움 퍼프린젠스 균 증식 억제 용도

Also Published As

Publication number Publication date
KR101823860B1 (ko) 2018-01-31
RU2019127080A3 (es) 2021-03-24
CN110719953B (zh) 2023-09-01
RU2019127080A (ru) 2021-03-24
MX2019009964A (es) 2019-10-14
WO2018155814A1 (ko) 2018-08-30
RU2748805C2 (ru) 2021-05-31
US20200054042A1 (en) 2020-02-20
US11529406B2 (en) 2022-12-20
CN110719953A (zh) 2020-01-21

Similar Documents

Publication Publication Date Title
CO2019010062A2 (es) Novedoso bacteriófago clo-pep-2 de clostridium perfringens y su uso para inhibir la proliferación de clostridium perfringens
BR112017013233A2 (pt) bacteriófago clo-pep-1 de clostridium perfringens inovador e uso do mesmo para a inibição de proliferação de clostridium perfringens
CO2018006947A2 (es) Novedoso bacteriófago pas-mup-1 de pasteurella multocida y su uso para inhibir la proliferación de pasteurella multocida
MX2020002727A (es) Nuevo uso para tratamiento de infecciones por clostridium difficile.
MX2017008563A (es) Novedoso bacteriófago esc-cop-1 de e. coli tipo f18 productora de toxina shiga y su uso para inhibir la proliferación de e. coli tipo f18 productora de toxina shiga.
CO2017006496A2 (es) Bacteriófago de e. coli enteroinvasiva esc-cop-4 para inhibir la proliferación de e. coli enteroinvasiva
MX2020001525A (es) Composiciones de peptido similar al glucagon tipo 1 (glp-1) y sus usos.
CL2019003892A1 (es) Nuevos derivados de azaquinolina.
CL2011002494A1 (es) Compuestos derivados de 7-aza-di-espiro-[3.0.4.1]-decan-8-carboxamida; composición farmacéutica que los comprenden; y uso para el tratamiento de un trastorno asociado con el virus de la hepatitis c (hcv) y el virus de inmunodeficiencia humana (vih).
PH12016500473B1 (en) Pcv2b divergent vaccine composition and methods of use
MX2017011655A (es) Compuestos de aza-piridona y usos de estos.
PH12016502001A1 (en) Novel bacteriophage and composition comprising same
PH12016501999A1 (en) Novel bacteriophage and composition containing same
WO2018097603A3 (ko) 중동호흡기증후군 코로나바이러스 s 단백질 면역원 조성물 및 이의 제작 방법
CU20210061A7 (es) Composición vacunal que comprende el dominio alfa 3 de mica/b para el tratamiento del cáncer
WO2018155813A3 (ko) 엔테로코쿠스 패슘에 대하여 용균력을 가지는 신규한 항균단백질 efal-2
CO2020010533A2 (es) Novedoso bacteriófago de salmonella heidelberg sal-hep-1 y su uso para inhibir el crecimiento de las bacterias de salmonella heidelberg
WO2019235782A8 (ko) 신규한 스트렙토코커스 수이스 박테리오파지 str-sup-2 및 이의 스트렙토코커스 수이스 균 증식 억제 용도
AR083445A1 (es) siARN CONTRA LA FIBROSIS
BR112016015875A2 (pt) Elementos intensificadores de cpmv
WO2019039781A3 (ko) 신규한 에로모나스 살모니시다 박테리오파지 ａｅｒ-ｓａｐ-2 및 이의 에로모나스 살모니시다 균 증식 억제 용도
IL274363B2 (en) Use of a specific siRNA against protein S for the treatment of hemophilia
PH12016502000A1 (en) Novel bacteriophage and composition comprising same
MX2021000949A (es) Nueva cepa de virus atenuada y su uso como una vacuna.
WO2018236086A3 (ko) 신규한 에로모나스 하이드로필라 박테리오파지 Aer-HYP-2 및 이의 에로모나스 하이드로필라 균 증식 억제 용도